Both constructs targeting BIRC5 show similar reduction of cell viability at eight days post infection (BIRC5-B = 0.62 +/-0.1 and BIRC5-C = 0.69 +/- 0.14), whereas the construct HSPA8-A shows much weaker effects (0.86 +/-0.15). The gene discussed is HSPA8; the disease is infection.